Health Trials

Postmenopausal Women With Osteoporosis

2

Review clinical trials related to Postmenopausal Women With Osteoporosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

This is a multicenter, randomized, open-label, parallel-controlled Phase II study designed to evaluate the differences in safety among four different dosing regimens of SAL056.

Participants needed: 200
Trial details
Phase: Phase 2Age: 45-80Biological sex: FemaleType: InterventionalSponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.Updated: May 12, 2026Locations: 1
Eligibility criteria

Received teriparatide treatment within 1 month prior to screening; [+5]

Read more
Status: Not yet recruiting

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

The purpose of this study is to evaluate the efficacy and safety of QLG2128 in the treatment of postmenopausal women with osteoporosis and at high risk of fracture.

Participants needed: 282
Trial details
Phase: Phase 3Age: 50-85Biological sex: AllType: InterventionalSponsor: Qilu Pharmaceutical Co., Ltd.Updated: Mar 27, 2025
Eligibility criteria

Postmenopausal women who can walk freely (≥50 and ≤85 years); [+4]

In addition to postmenopausal osteoporosis, the other diseases affecting bone me... [+5]

Read more